Concept Architecture
Concept
Theoretically, Hierarchical Testing is a multiple testing procedure in which hypotheses are tested in a predefined sequence to control the family-wise error rate while preserving statistical power. It is founded on the theory of multiple hypothesis testing and closed testing procedures. The concept exists because testing numerous hypotheses independently inflates the probability of Type I error. By requiring higher-priority hypotheses to achieve statistical significance before lower-priority hypotheses are evaluated, hierarchical testing controls the overall probability of false-positive conclusions.
Mathematically, hierarchical testing represents a sequential decision process in which each hypothesis is tested at a specified significance level only if all preceding hypotheses in the hierarchy have been rejected. The procedure commonly uses fixed-sequence testing, although more complex gatekeeping strategies may allocate significance levels across multiple hypothesis families. Because no alpha is spent on hypotheses that are not tested, the overall family-wise error rate remains controlled without requiring alpha adjustment within the sequence.
In practice, hierarchical testing is prespecified within the statistical analysis plan before trial commencement. Primary, secondary and exploratory endpoints are ordered according to clinical importance, and testing proceeds only while statistical significance is maintained. In health economics, hierarchical testing is frequently used in clinical trials supporting health technology assessment, ensuring that treatment claims for secondary outcomes are valid only when primary efficacy objectives have been satisfied.
Purpose
Used to control the family-wise Type I error rate while evaluating multiple hypotheses in a predefined order, supporting statistically valid inference for primary and secondary trial endpoints.
Mathematical Formulae
Primary Formula
Sequential testing rule:
Reject H? only if
p? � �, p? � �, ? , p? � �
where:
- H? = hypothesis k
- p? = p-value for hypothesis k
- � = family-wise significance level
Supporting Formulae
Family-wise error rate:
FWER = P(V � 1)
where:
- V = number of false rejections
Fixed-sequence decision rule:
If p? > �, then all remaining hypotheses H???, ? , H? are not formally tested.
Related Mathematical Methods
- Fixed-Sequence Testing
- Gatekeeping Procedures
- Closed Testing Procedure
- Bonferroni Procedure
- Holm Procedure
- Family-Wise Error Rate Control
- Multiple Hypothesis Testing
Example
A phase III oncology trial specifies the following testing hierarchy:
- Overall survival
- Progression-free survival
- Health-related quality of life
At � = 0.05:
- Overall survival: p = 0.018 ? significant
- Progression-free survival: p = 0.031 ? significant
- Health-related quality of life: p = 0.082 ? not significant
Testing stops after the third hypothesis. Because the testing sequence was followed, the overall family-wise Type I error rate remains controlled at 5%.
Excel Implementation
| Function | Example Formula | Health Economics Application |
|---|---|---|
| IF | =IF(B2<=0.05,"Continue","Stop") | Determines whether testing proceeds to the next hypothesis. |
| AND | =AND(B2<=0.05,B3<=0.05) | Verifies that preceding hypotheses satisfy the testing hierarchy. |
| COUNTIF | =COUNTIF(B2:B10,"<=0.05") | Counts statistically significant hypotheses within the sequence. |
| IF | =IF(AND(B2<=0.05,B3<=0.05,B4<=0.05),"Reject","Retain") | Applies a fixed-sequence decision rule across multiple endpoints. |
VBA (Optional)
Automate sequential hypothesis testing by evaluating p-values in their prespecified order and terminating formal testing once a non-significant result is encountered.
Sources
- Dmitrienko A, Tamhane AC, Bretz F. Multiple Testing Problems in Pharmaceutical Statistics.
- Bretz F, Hothorn T, Westfall P. Multiple Comparisons Using R.
- ICH E9. Statistical Principles for Clinical Trials.
- EMA. Guideline on Multiplicity Issues in Clinical Trials.
- FDA. Multiple Endpoints in Clinical Trials Guidance for Industry.
- NICE. Health Technology Evaluation Manual.
Related Concepts (2)
Library
Publications
1
Bayesian Methods in Health Economics — Gianluca Baio, 1st Edition ed., 2012 (Chapman & Hall / CRC Press)
An overview of Bayesian statistical methods for the analysis of health economic data, covering economic evaluation concepts, statistical cost-effectiveness analysis, Bayesian computation and MCMC, and applied health economic evaluation.
BookView source →
Frequently Asked Questions (6)
What is hierarchical testing?
A multiple testing strategy organising hypotheses into a prespecified sequence, so later tests are only conducted if earlier, higher-priority tests succeed.
Source: Dmitrienko, Tamhane & Bretz 2009
How does hierarchical testing order a trial's hypotheses?
Hierarchical testing arranges a trial's hypotheses into a fixed sequence set in advance, testing them one after another and stopping as soon as one fails. Ordering them this way controls the overall risk of a false positive without splitting the significance level across them, because each test is reached only if every earlier, higher-priority one succeeded. This lets several endpoints be claimed in turn while keeping the family-wise error rate in check. Testing hypotheses in a preset order is its method. Friedman and colleagues (2015) describe this strategy.
Source: Friedman et al. 2015
How does hierarchical testing control the error rate?
Hierarchical testing controls the overall type I error by fixing the order of hypotheses in advance and testing each only if all earlier ones were rejected, so that the full significance level can be used at each step without inflating the overall error. Because later tests occur only after earlier successes, no adjustment to the individual significance levels is needed. So hierarchical testing controls the error rate through the prespecified sequence and the stopping rule, which ensures that the chance of any false positive across the sequence stays at the intended level, allowing each hypothesis to be tested at the full level while preserving overall control.
Source: Dmitrienko, Tamhane & Bretz 2009
How does hierarchical testing differ from gatekeeping?
Hierarchical testing tests hypotheses in a strict prespecified sequence, each tested only if the previous was significant, while gatekeeping generalises this to ordered families of hypotheses with gates between them, offering more flexibility in how error is allocated across the families. Hierarchical testing is essentially the simplest gatekeeping structure. So hierarchical testing and gatekeeping are related strategies, with hierarchical, or fixed-sequence, testing a linear ordering of individual hypotheses and gatekeeping a broader framework of ordered families, both using prespecified priorities to control multiplicity, and the choice depends on whether a simple sequence or a more complex structure of hypothesis families is required.
Source: Dmitrienko, Tamhane & Bretz 2009
When is hierarchical testing used?
Hierarchical testing is used when hypotheses can be ranked by importance in advance and it is acceptable to test lower-priority ones only if higher-priority ones succeed, as with a primary endpoint followed by ordered secondary endpoints in a trial. So hierarchical testing is used to structure the testing of multiple endpoints or hypotheses by priority, allowing confirmatory conclusions on secondary hypotheses when the primary ones are significant, which is common in clinical trials, since it controls multiplicity while reflecting the relative importance of the hypotheses and avoids the loss of power that adjusting all tests equally would cause.
Source: Dmitrienko, Tamhane & Bretz 2009
What are the limitations of hierarchical testing?
The limitations of hierarchical testing include that once a hypothesis in the sequence fails to reach significance, testing stops and all later hypotheses cannot be formally concluded, even if their evidence is strong; and that the ordering must be fixed in advance and cannot be changed by the data. So hierarchical testing is used with awareness that its strict sequence can prevent conclusions on later hypotheses if an earlier one fails, regardless of their own results, which is a trade-off for its simplicity and error control, and this is why the ordering is chosen carefully in advance and more flexible gatekeeping structures are sometimes preferred when several hypotheses matter.
Source: Dmitrienko, Tamhane & Bretz 2009
Trust Record
Verified by Dr Darrin Baines
British health economist
Professional identity: darrinbaines.org
Verification date: 16 Dec 2025
Content version: 1.0.0
Canonical Identity
- Term code
- HE-ES-SA-078
Stable URI · Machine-readable · Resolvable · CC BY 4.0